Dr. Yankey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Philadelphia, PA 19111Phone+1 774-823-9763
Education & Training
- Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2020 - 2024
- Crozer-Chester Medical CenterInternship, Transitional Year, 2019 - 2020
- Lewis Katz School of Medicine at Temple UniversityClass of 2019, MD
- Drexel University BS, Cell/Molecular Biology & Genetics, Magna Cum Laude, 2011 - 2014
- University of Ghana School of PharmacyBS, 2010 - 2011
Certifications & Licensure
- PA State Medical License 2019 - 2024
Awards, Honors, & Recognition
- Excellence in Research Award Crozer Chester Medical Center, 2020
- TUSM Academic Achievement Award Temple University School of Medicine, 2015-2019
Publications & Presentations
PubMed
- Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation.Hilario Yankey, Karen J Ruth, Efrat Dotan, Sanjay Reddy, Joshua E Meyer
Advances in Radiation Oncology. 2024-04-01 - 12 citationsAdverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.Rebecca M Shulman, David S Weinberg, Eric A Ross, Karen Ruth, Glenn F Rall
Journal of the National Comprehensive Cancer Network. 2022-02-01 - 17 citationsRenal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy.Andres F. Correa, Hilary Yankey, Tianyu Li, Shreyas Joshi, Alexander Kutikov
Urology. 2019-01-01
Journal Articles
- Survival and Toxicity in Patients with Unresectable or Inoperable Biliary Tract Cancers with Ablative Radiotherapy versus Non-Ablative ChemoradiationHilario Yankey; Karen J. Ruth; Efrat Dotan; Sanjay Reddy; Joshua E. Meyer, Advances in Radiation Oncology, 12/1/2023
- Absence of fibrosis after Stereotactic Body Radiation Therapy (SBRT) for hepatocellular carcinoma (HCC) in a multiple-transplant patientYankey H, Meyer JE, Anaokar J, Applied Radiation Oncology, 12/20/2018
Books/Book Chapters
Abstracts/Posters
- Survival and toxicity in patients with unresectable/inoperable biliary cancers treated with SBRT versus conventionally fractionated chemoradiationHilario N. Yankey, Karen J. Ruth, Efrat Dotan, Sanjay Reddy, Tim Dougherty, Aneesh Pirlamarla and Joshua E. Meyer, ASTRO 2021, Chicago, IL, USA
- Long Term Outcomes of Stereotactic Radiosurgery for Brain Metastases from Lung Cancer in the era of immunotherapyYankey, H., Cantalino, J., Lanciano, R., Feng, J., Arrigo, S., Lamond, John., Hanlon, A, L., Lozano, A., Yang, J., Giesa, C., Crozer Keystone Health System Residency Research Day, Upland, PA, 5/27/2020
- Completion Rate And Toxicity Of Hypo-Fractionated Radiotherapy For Retroperitoneal And Pelvic Soft Tissue SarcomasYankey, H., Hollawell, C., Ross, E., Farma, J. M., Esnaola, N., Meyer, J., von Mehren, M., Reddy, S., Abraham, J., Movva, S., Howell, K. J., Connective Tissue Oncology Society, Rome, Italy, 11/2018
Professional Memberships
- Member
- SNMATreasurer 2016- 2017
- LMSAMember
- Member
- Member
- American Board of RadiologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: